Post

New research · Ophthalmology
Ophthalmology science · 2d
Animal / preclinicalOphthalmology science · 2026

Topotecan Microneedle Scleral Patch: A Transscleral Drug Delivery Study for Retinoblastoma.

Vishal Raval, R Arawindh, Sharayu Naik … Venkata Vamsi Krishna Venuganti
Read paper
OphthalmologyAnimal / preclinical

Microneedle scleral patch delivered topotecan selectively to the retina in rabbits

Topotecan Microneedle Scleral Patch: A Transscleral Drug Delivery Study for Retinoblastoma.

Vishal Raval … Venkata Vamsi Krishna Venuganti
Ophthalmology science · 2026
Purpose

We aimed to design, fabricate, and evaluate the pharmacokinetic properties of topotecan loaded with microneedle scleral patch (microneedle scleral patch) in rabbit eye.

Methods

The microneedle scleral patch was fabricated using a 3-dimensional printed master mold.

n = 9 eyes
Results

retina held far more drug than blood, showing highly targeted delivery

275fold
MSP
58.9fold
Intra-arterial chemoth
1.32fold
Intravenous chemothera
More results

The dimensions of microneedles were uniform across the array measuring 548 ± 3.7 μm length, 336 ± 7.5 μm width, and 18 μm tip diameter.

In the ex vivo goat eye model, the required insertion force was 0.026 N per needle, which was 50 times lower than the compression strength of 1.27 N per needle.

More results

The microneedles were inserted up to a depth of 225 μm.

At 8 hours, the drug level was undetectable (0.02 ± 0.01 μg/g).

“
Conclusion · 1 of 2

A single topotecan-loaded microneedle scleral patch (100 μg) achieved highly selective retinal tissue distribution, with a retinal-to-plasma ratio of 275-fold, which was 4.7-fold higher than intra-arterial chemotherapy (58.9) and 209-fold higher than intravenous chemotherapy (1.32), supporting its potential benefit for RB treatment.

Conclusion · 2 of 2

FINANCIAL

Read paper
0 comments

No comments yet. Be the first.

Related papers

LatestFoundational
Cross-sectional
44.1%
had too much homocysteine in the blood, a far larger share than in dry AMD or healthy eyes
Cohort Study
92.3%
most laser-treated eyes had a favorable eye-structure outcome
Cohort Study
56%
lost three or more lines on the eye-chart vision test
Cohort Study
50%
older patients were more likely to lose three or more lines of vision
Study
81%
trials where mask air leaks were detected blowing toward the eyes
Cohort Study
13.5%
Central retinal artery peak blood-flow speed was 13.5% lower in diabetic patients.
Study
379 +/- 156 microm
lower thickness in the central retina, checked with an eye scan
Case Report
9 of 10 eyes
eyes had better measured vision after treatment